Bivision
Shanghai
About Bivision
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $42.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: bivisionpharma.com
- Phone: 021-50886896
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics
Canonical: https://fsome.com/organization/bivision-73586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.